4//SEC Filing
OYSTER POINT PHARMA I, LLC 4
Accession 0000899243-19-026634
CIK 0001720725other
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 6:05 AM ET
Size
7.6 KB
Accession
0000899243-19-026634
Insider Transaction Report
Form 4
OYSTER POINT PHARMA I, LLC
10% Owner
Transactions
- Conversion
Common Stock, par value $0.001 per share
2019-11-04+955,392→ 955,392 total - Conversion
Series B Convertible Preferred Stock
2019-11-04−955,392→ 0 total→ Common Stock, par value $0.001 per share (955,392 underlying)
Footnotes (2)
- [F1]These shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date.
- [F2]Consists of 955,392 shares of common stock beneficially owned by Oyster Point Pharma I, LLC. William J. Link, as a managing partner of Oyster Point Pharma I, L.L.C., may be deemed to share voting and dispositive power over the shares held by Oyster Point Pharma I, LLC.
Documents
Issuer
Oyster Point Pharma, Inc.
CIK 0001720725
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001769046
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 6:05 AM ET
- Size
- 7.6 KB